As such, in many patient specimens and animal models, the loss of LKB1-AMPK signaling alters cell growth and repair mechanisms triggering cancer development.61, 62, 63 Furthermore, AMPK agonists and pharmacological compounds that activate AMPK, such as cafestol and β-ionone disrupt tumor progression.64 This evidence concerns the gene STK11 and neoplasm.